Brief: TELA Bio Q4 Revenue USD 16.998 Million Vs. IBES Estimate USD 16.4 Million
21/03/2024 20:05
Mar 21 (Reuters) - TELA Bio Q4 basic EPS USD -0.53. * Q4 net income USD -12.89 million * Q4 operating expenses USD 23.902 million * Q4 income from operations USD -12.278 million * Q4 gross profit USD 11.624 million * outlook FY revenue USD 74-76 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants